Phase I Trial of Monoclonal Antibody muJ591 in Patients With Hormone-Independent Prostate Cancer.
Phase of Trial: Phase I
Latest Information Update: 20 Oct 2009
At a glance
- Drugs J 591 (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 20 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Sep 2005 New trial record.